Nextech Invest — 2023 Investments

3 investments dated 2023 · listed companies and verified rows first · show all

CARGO Therapeuticscargo-tx.com inFeb 2023

Launched by Samsara in partnership with CAR T pioneers, advancing a clinically validated CD22 CAR T for lymphoma.

BiotechSan Mateo, US

Gina Chapman(Executive Officer, Director)Anup Radhakrishnan(Executive Officer)Cassandra Gianna Luca(Director)Jeffrey Walsh(Director)Krishnan Viswanadhan(Director)

BoardAbraham Bassan(Director)

Co-investorsRed Tree Venture Samsara BioCapital Ally Bridge Group Janus Henderson Investors Perceptive Xontogeny Venture Third Rock Ventures

K36 Therapeuticsk36tx.com in 𝕏Jun 2023 · $70M

A biotechnology company developing cancer therapies for patients with unmet medical needs.

BiotechHealthtech

Co-investorsAtlas Venture F-Prime Capital Eight Roads Ventures

Mariana Oncologymarianaoncology.com in 𝕏Sep 2023 · $175M

Mariana Oncology, a Novartis company, develops precision radioligand therapies that deliver radioisotopes to diseased cells while limiting effects on healthy tissue.

BiotechHealthtechMedical Devices

Co-investorsAccess Biotechnology Atlas Venture Forbion RA Capital

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.